Completed NA INTERVENTIONAL 3-arm NCT00999297

Effect of 4-week Dihydrocapsiate Ingestion on Resting Metabolic Rate (CAPSPAL)

Effect of 4-week Dihydrocapsiate Ingestion on Resting Metabolic Rate: A Double-blind Randomized Parallel Arm Study

Sponsor: Ajinomoto USA, INC.

Updated 5 times since 2017 Last updated: Nov 18, 2015 Started: Jul 31, 2008 Primary completion: Nov 30, 2009 Completion: Dec 31, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Obesity and Weight and is currently completed. Ajinomoto USA, INC. leads this study, which shows 5 recorded versions since 2008 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA
Jan 2017 — Jun 2018 [monthly]

Completed NA

First recorded

Jul 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Ajinomoto USA, INC.
Pennington Biomedical Research Center

Data source: Pennington Biomedical Research Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Baton Rouge, United States